Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has issued an update.
Wai Chun Bio-Technology Limited has announced significant changes in its board of directors and committee compositions effective June 5, 2025. The company has accepted the resignations of Mr. Wan Bo and Mr. He Tao from their roles as independent non-executive directors and committee chairmen, citing personal commitments. In their place, Ms. Xu Huiling and Mr. Wang Ziniu have been appointed as independent non-executive directors, with Mr. Wang taking over as Chairman of the Remuneration Committee. These changes reflect a strategic shift in the company’s governance structure, potentially impacting its operational focus and stakeholder relations.
More about Wai Chun Bio-Technology Ltd.
Average Trading Volume: 110,064
Technical Sentiment Signal: Hold
Current Market Cap: HK$21.95M
For detailed information about 0660 stock, go to TipRanks’ Stock Analysis page.